Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure. β
mSphere (mSphere ) Vol: 5 Issue 1 Pages: Pub: 2020 Jan 29 Epub: 2020 Jan 29 Authors Wang K , Lv L , Yan R , Wang Q , Jiang H , Wu W , Li Y , Ye J , Wu J , Yang L , Bian X , Jiang X , Lu Y , Xie J , Wang Q , Shen J , Li L , |
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. β
Go to Publication β
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 22 Epub: 2022 Dec 22 Authors Shi S , Zhang Q , Sang Y , Ge S , Wang Q , Wang R , He J , |
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. β
Go to Publication β
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]